Hello
Hello! How can I help you today?
I want you to explain me prilocaine
Reading Document
Medical Text Search
prilocaine local anesthetic mechanism of action pharmacology
Medical Text Search
prilocaine clinical uses dosage toxicity methemoglobinemia
GradeResponse
GradeResponse
The retrieved content touches on prilocaine but is limited. I'll now provide a comprehensive explanation drawing from both retrieved sources and my own knowledge.
Prilocaine
Overview
Prilocaine is an amide-type local anesthetic (like lidocaine, bupivacaine, and mepivacaine). It was introduced in the 1960s and is notable for its low systemic toxicity compared to other amides, though it carries a unique risk of methemoglobinemia.
Mechanism of Action
Like all local anesthetics, prilocaine works by blocking voltage-gated sodium (Na⁺) channels in neuronal cell membranes. Specifically:
- It diffuses across the cell membrane in its uncharged (base) form.
- Inside the cell, it re-protonates and binds to the intracellular side of the Na⁺ channel.
- This prevents Na⁺ influx, halting depolarization and propagation of action potentials.
- The result is a reversible loss of sensation (and sometimes motor function) in the targeted area.
Pharmacokinetics
| Property | Detail |
|---|---|
| Class | Amide |
| Onset | Intermediate (2–5 min) |
| Duration | 1–2 hours (plain); longer with epinephrine |
| Protein binding | ~55% |
| Metabolism | Liver (and also lung/kidney) — hydrolysis to o-toluidine (the metabolite responsible for methemoglobinemia) |
| Elimination | Renal |
| Lipid solubility | Moderate |
Clinical Uses
- Dental anesthesia: widely used for infiltration and nerve blocks in dentistry, often combined with felypressin (a vasoconstrictor used instead of epinephrine) as Citanest.
- Topical anesthesia: combined with lidocaine in the famous EMLA cream (Eutectic Mixture of Local Anesthetics), used to anesthetize skin before IV cannulation, venipuncture, or minor dermatological procedures.
- Regional anesthesia: peripheral nerve blocks, epidural anesthesia (though less common today).
- Intravenous regional anesthesia (Bier block): preferred over lidocaine in some settings due to its lower cardiac toxicity.
Dosage (Adult)
- Infiltration: up to 400 mg (without epinephrine); up to 600 mg (with vasoconstrictor)
- EMLA cream: typically 2.5% prilocaine + 2.5% lidocaine applied under occlusion for 45–60 min
Key Advantage: Lower Systemic Toxicity
Prilocaine has a lower affinity for cardiac sodium channels than bupivacaine or lidocaine, giving it a wider safety margin for cardiovascular toxicity. This makes it particularly useful in Bier blocks, where inadvertent systemic release of the anesthetic is possible (Epidural Interventions in the Management of Chronic Spinal Pain, p. 112).
Major Adverse Effect: Methemoglobinemia
This is the most clinically significant and unique risk of prilocaine.
- Mechanism: The metabolite o-toluidine oxidizes hemoglobin Fe²⁺ to Fe³⁺ (methemoglobin), which cannot carry oxygen.
- Dose-dependent: Risk increases significantly above 600 mg in adults.
- Symptoms: Cyanosis, hypoxia, headache, dizziness, dyspnea — unresponsive to supplemental O₂.
- Diagnosis: SpO₂ reads ~85% on pulse oximetry regardless of true saturation; confirmed by co-oximetry (MetHb > 1%).
- Treatment: Methylene blue 1–2 mg/kg IV, which reduces MetHb back to functional hemoglobin.
Note: Benzocaine and lidocaine can also cause methemoglobinemia, but it is far more characteristically associated with prilocaine (p. 112).
Contraindications / Cautions
- Neonates and infants < 3 months: immature enzyme systems (reduced methemoglobin reductase) make them especially vulnerable to methemoglobinemia. EMLA is used cautiously or avoided.
- G6PD deficiency: increases methemoglobinemia risk.
- Anemia or existing hypoxia.
- Congenital or acquired methemoglobinemia.
- Allergy to amide local anesthetics (rare).
Comparison to Similar Agents
| Feature | Prilocaine | Lidocaine | Bupivacaine |
|---|---|---|---|
| Class | Amide | Amide | Amide |
| Duration | Moderate | Moderate | Long |
| Cardiac toxicity | Low | Moderate | High |
| Methemoglobinemia risk | High | Low | Very low |
| Common use | Dental, EMLA | Wide-ranging | Epidural, nerve blocks |
Summary
Prilocaine is a versatile, well-tolerated local anesthetic with a favorable cardiac safety profile. Its main clinical niches are dental anesthesia and EMLA cream. The primary concern is methemoglobinemia from its o-toluidine metabolite, which limits its use in high doses and in vulnerable populations (neonates, G6PD-deficient patients). Methylene blue is the antidote when methemoglobinemia occurs.
This is a shared conversation. Sign in to Orris to start your own chat.